D012751DisordersC04.557.386.480.750.800.775C15.604.515.569.480.750.800.775C15.604.515.841C20.683.515.761.480.750.800.775C20.683.515.920Sezary Syndromeprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfConnectionsnumber of connectionsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierInformation Resourcevivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConcept7947487Neish C, Charlry M, Jegasothy B, Tharp M, Deng JSJournal of dermatological scienceProliferation cell nuclear antigen and soluble interleukin 2 receptor levels in cutaneous T cell lymphoma: correlation with advanced clinical diseases. J Dermatol Sci. 1994 Aug; 8(1):11-7.J Dermatol Sci1994-08-01T00:00:001994Proliferation cell nuclear antigen and soluble interleukin 2 receptor levels in cutaneous T cell lymphoma: correlation with advanced clinical diseases.8632073D'Ambra-Cabry K, Tharp MD, Jagasothy BV, Deng JSJournal of the American Academy of DermatologyIgG anti-50 kd lymphocyte membrane peptide antibody in patients with S?zary syndrome. J Am Acad Dermatol. 1996 May; 34(5 Pt 1):777-80.J Am Acad Dermatol1996-05-01T00:00:001996IgG anti-50 kd lymphocyte membrane peptide antibody in patients with S?zary syndrome.10456362Stevens SR, Bowen GM, Duvic M, King LE, Knobler R, Lim HW, Margolis D, Parry EJ, Rook AH, Stricklin GP, Suchin KR, Tharp MD, Vonderheid E, Zic JAArchives of dermatologyEffectiveness of photopheresis in S?zary syndrome. Arch Dermatol. 1999 Aug; 135(8):995-7.Arch Dermatol1999-08-01T00:00:001999Effectiveness of photopheresis in S?zary syndrome.0.1810290.03200323subject area for